Targeted delivery of RGD-modified liposomes encapsulating both combretastatin A-4 and doxorubicin for tumor therapy: in vitro and in vivo studies.
about
Recent Developments in Active Tumor Targeted Multifunctional Nanoparticles for Combination Chemotherapy in Cancer Treatment and ImagingEngineered Nanoparticles Against MDR in Cancer: The State of the Art and its Prospective.Recent trends in multifunctional liposomal nanocarriers for enhanced tumor targetingUse of Nanotechnology to Develop Multi-Drug Inhibitors For Cancer TherapyMultifunctional nanocarriers for simultaneous encapsulation of hydrophobic and hydrophilic drugs in cancer treatment.Multifunctional dendrimer/combretastatin A4 inclusion complexes enable in vitro targeted cancer therapy.Microfluidic synthesis of rigid nanovesicles for hydrophilic reagents deliveryMultifunctional particles for melanoma-targeted drug delivery.Tumor vascular-targeted co-delivery of anti-angiogenesis and chemotherapeutic agents by mesoporous silica nanoparticle-based drug delivery system for synergetic therapy of tumor.A novel submicron emulsion system loaded with vincristine-oleic acid ion-pair complex with improved anticancer effect: in vitro and in vivo studies.The functions and applications of RGD in tumor therapy and tissue engineering.Ellipsoidal Polyaspartamide Polymersomes with Enhanced Cell-Targeting AbilityLiposomes targeting tumour stromal cells.Drug delivery systems for differential release in combination therapy.Recent advances in ligand targeted therapy.Nanoscale delivery systems for multiple drug combinations in cancer.Peptide targeted lipid nanoparticles for anticancer drug delivery.Receptor-based targeting of therapeutics.Tumour vasculature targeting agents in hybrid/conjugate drugs.Targeted delivery of nano-therapeutics for major disorders of the central nervous system.Nanoscale particulate systems for multidrug delivery: towards improved combination chemotherapy.Materials innovation for co-delivery of diverse therapeutic cargos.PEG-lipid micelles as drug carriers: physiochemical attributes, formulation principles and biological implication.Review peptide-targeted liposomes for selective drug delivery: Advantages and problematic issues.Pleiotropic Role of Dietary Phytochemicals in Cancer: Emerging Perspectives for Combinational Therapy.Strategies for improving the intratumoral distribution of liposomal drugs in cancer therapy.Cancer nanomedicine: progress, challenges and opportunities.Incorporation of a selective sigma-2 receptor ligand enhances uptake of liposomes by multiple cancer cells.Targeting to overexpressed glucose-regulated protein 78 in gastric cancer discovered by 2D DIGE improves the diagnostic and therapeutic efficacy of micelles-mediated system.Spatiotemporally controlled co-delivery of anti-vasculature agent and cytotoxic drug by octreotide-modified stealth liposomes.Nanotechnology-based combination therapy for overcoming multidrug-resistant cancer.Recent progress in multidrug delivery to cancer cells by liposomes.RGD Peptide-Based Target Drug Delivery of Doxorubicin Nanomedicine.Novel, nano-sized, liposome-encapsulated polyamidoamine dendrimer derivatives facilitate tumour targeting by overcoming the polyethylene glycol dilemma and integrin saturation obstacle.Peptide Mediated In Vivo Tumor Targeting of Nanoparticles through Optimization in Single and Multilayer In Vitro Cell Models.Determining the Radiation Enhancement Effects of Gold Nanoparticles in Cells in a Combined Treatment with Cisplatin and Radiation at Therapeutic Megavoltage Energies.Microfluidic Synthesis of Rigid Nanovesicles for Hydrophilic Reagents Delivery
P2860
Q26778234-9704CFF9-E48F-4F7E-BA2A-F4D71CB4985FQ28073956-60B7EFEF-89D7-4AAD-A01C-C5F54011D7DDQ30456053-4DED1CB3-5D36-406D-9C48-1A456A4C00F1Q33859472-ECBDC5C6-374C-421D-93EF-46833A1A141DQ34440323-4E574BA4-F125-4632-AB30-169BCE996FA0Q35488068-D25F5858-158D-47D8-BCE4-5D7C020C2C24Q35753701-41ABE499-83B2-44DC-AA35-F6415F79BA60Q36074733-A87BBCB5-7CAB-49A0-89C2-C0C8D1D38C3BQ36425431-33D7F7E3-B24B-44DC-935B-9D352AB683DBQ36714048-D02C21B1-BA41-4595-A3AC-04365612993CQ37091818-6284D947-80B9-4BC3-BB82-26E447D05EC8Q37109774-6B1F4662-2E75-45F5-A434-8A3C6AFAF69FQ37799613-3B39C42E-A881-461C-80B8-75491BDCD3C7Q37827881-E3CA173E-A096-4475-A33A-62486C8DC78EQ37937611-FC10E077-012A-42BA-A1A7-06DA4C9C73EFQ37951607-B8590D77-C350-45EF-8B34-2B9CE2925DA6Q38016810-8E0BFF98-AA2B-442D-A74A-E6FC9938FBA2Q38084739-DEFAE3FB-75CD-4F34-B476-3A3744C0EEFFQ38094627-7E437895-1EC7-4561-8CDB-70A08BC412E4Q38116765-741F5736-7193-4AF4-9714-72CC3CE8A513Q38183852-B416BCBA-939C-4B03-8FE3-6E29F132E67AQ38211033-60644712-44E2-4A3D-848C-A02326541AA8Q38303124-98B10E34-3C9E-4591-B23B-3AEFD8EBE354Q38502588-5CB5A809-340C-4B5E-996E-E30791FE6916Q38584742-0D12D97D-2DD8-4692-B81B-899B57CA8C70Q38776676-DDD9C227-FD3D-4BA1-A10B-2EABB18A58DEQ39005226-7F2F5209-1CC0-45A8-B84A-EE1A3FBB7B6AQ39289664-4128184A-0E8D-4E45-A0DF-844E480D64EFQ39317293-8A35FB14-ACA4-48EB-B331-1C218A570FB5Q39326977-2265DF20-A39D-4A3F-8EE9-3CB5BDA43475Q41514180-778ADF00-05A3-4F48-8987-F38458E1C8C3Q44874958-86EAE0DF-E58E-422A-8AED-DA45CB154073Q46507854-81174290-F227-4BEE-A7E6-9C083757C424Q47324492-9C71F0EA-100C-4D43-9C3A-762C96F6132DQ52646682-2B472348-9B22-49B3-A1A4-ADA529DF62C0Q54946110-19580571-72DC-4203-BFC7-B14EF0A50CDFQ57238661-9736BD76-6783-47CC-ABB9-80797B905DEC
P2860
Targeted delivery of RGD-modified liposomes encapsulating both combretastatin A-4 and doxorubicin for tumor therapy: in vitro and in vivo studies.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Targeted delivery of RGD-modif ...... in vitro and in vivo studies.
@ast
Targeted delivery of RGD-modif ...... in vitro and in vivo studies.
@en
Targeted delivery of RGD-modif ...... in vitro and in vivo studies.
@nl
type
label
Targeted delivery of RGD-modif ...... in vitro and in vivo studies.
@ast
Targeted delivery of RGD-modif ...... in vitro and in vivo studies.
@en
Targeted delivery of RGD-modif ...... in vitro and in vivo studies.
@nl
prefLabel
Targeted delivery of RGD-modif ...... in vitro and in vivo studies.
@ast
Targeted delivery of RGD-modif ...... in vitro and in vivo studies.
@en
Targeted delivery of RGD-modif ...... in vitro and in vivo studies.
@nl
P2093
P1476
Targeted delivery of RGD-modif ...... in vitro and in vivo studies.
@en
P2093
Dong-Yan Bian
Jian-Cheng Wang
Qiang Zhang
Xuan Zhang
Yi-Fei Zhang
P304
P356
10.1016/J.EJPB.2010.01.002
P407
P577
2010-01-11T00:00:00Z